Skip to main content
. 2022 Feb 16;2022(2):CD007929. doi: 10.1002/14651858.CD007929.pub4

4.5. Analysis.

4.5

Comparison 4: Platinum‐sensitive recurrent EOC: PARPi monotherapy compared with chemotherapy, Outcome 5: Quality of Life ‐ Trial Outcome Index score of Functional Assessmentof Cancer Therapy—Ovarian Cancer questionnaire